Renal Denervation: 60 Second Insights
Published: 22 March 2019
-
Views:
8
-
Likes:
7
-
Views:
8
-
Likes:
7
-
Up Next
-
Part 5 | Session 1 Justin Davies
-
Part 5 | Session 2 Aloke Finn
-
Part 5 | Session 3 David Kandzari
-
Part 5 | Session 4 Horst Sievert
-
Part 5 | Session 5 Ajay Kirtane
-
Part 5 | Session 6 Robert Schwartz
-
Part 5 | Session 7 Gerald Werner
-
Part 6 | Session 1 Justin Davies
-
Part 6 | Session 2 Aloke Finn
-
Part 6 | Session 3 David Kandzari
-
Part 6 | Session 4 Horst Sievert
-
Part 6 | Session 5 Ajay Kirtane
-
Part 6 | Session 6 Robert Schwartz
-
Part 6 | Session 7 Gerald Werner
-
Part 7 Justin Davies
-
Part 8 Justin Davies
-
Part 9 | Session 1 Justin Davies
-
Part 9 | Session 2 David Kandzari
-
Part 10 | Session 1 Justin Davies
-
Part 10 | Session 2 David Kandzari
-
Part 11 | Session 1 Justin Davies
-
Part 11 | Session 2 Aloke Finn
-
Part 11 | Session 3 David Kandzari
-
Part 11 | Session 4 Horst Sievert
-
Part 11 | Session 5 Ajay Kirtane
-
Part 11 | Session 6 Robert Schwartz
-
Part 12 | Session 1 Justin Davies
-
Part 12 | Session 2 Aloke Finn
-
Part 12 | Session 3 David Kandzari
-
Part 12 | Session 4 Horst Sievert
-
Part 12 | Session 5 Ajay Kirtane
-
Part 12 | Session 6 Robert Schwartz
-
Part 13 | Session 1 Justin Davies
-
Part 13 | Session 2 Aloke Finn
-
Part 13 | Session 3 David Kandzari
-
Part 13 | Session 4 Horst Sievert
-
Part 13 | Session 5 Ajay Kirtane
-
Part 13 | Session 6 Robert Schwartz
-
Part 1 | Session 1 Justin Davies Justin E Davies
-
Part 1 | Session 2 Aloke Finn Aloke V Finn
-
Part 1 | Session 3 David Kandzari David E Kandzari
-
Part 1 | Session 4 Horst Sievert Horst Sievert
-
Part 1 | Session 5 Ajay Kirtane Ajay J Kirtane
-
Part 1 | Session 6 Robert Schwartz Robert S Schwartz
-
Part 2 | Session 1 Justin Davies Justin E Davies
-
Part 2 | Session 2 David Kandzari David E Kandzari
-
Part 2 | Session 3 Horst Sievert Horst Sievert
-
Part 2 | Session 4 Ajay Kirtane Ajay J Kirtane
-
Part 2 | Session 5 Robert Schwartz Robert S Schwartz
-
Part 2 | Session 6 Patrick Serruys Patrick W Serruys
-
Part 2 | Session 7 Gerald Werner Gerald S Werner
-
Part 2 | Session 8 Aloke Finn Aloke V Finn
-
Part 3 | Session 1 Justin Davies Justin E Davies
-
Part 3 | Session 2 Aloke Finn Aloke V Finn
-
Part 3 | Session 3 David Kandzari David E Kandzari
-
Part 3 | Session 4 Horst Sievert Horst Sievert
-
Part 3 | Session 5 Ajay Kirtane Ajay J Kirtane
-
Part 3 | Session 6 Robert Schwartz Robert S Schwartz
-
Part 4 | Session 1 Justin Davies Justin E Davies
-
Part 4 | Session 2 Aloke Finn Aloke V Finn
-
Part 4 | Session 3 David Kandzari David E Kandzari
-
Part 4 | Session 4 Horst Sievert Horst Sievert
-
Part 4 | Session 5 Ajay Kirtane Ajay J Kirtane
Overview
A short series of 60-second insight videos on renal denervation. Hear the expert views in under one minute!
More from this programme
Part 1
Thinking about patient preference, what role does RDN have in blood pressure control?
Part 2
What role do you see for renal denervation in control of blood pressure in your patients?
Part 3
Where does renal denervation fit in your current clinical practice?
Part 4
What are the biggest barriers to blood pressure control in your patients?
Part 5
Which patient groups are most receptive to RDN?
Part 6
What is needed to get widespread adoption into clinical practice?
Part 7
How have SPYRAL HTN-OFF and SPYRAL HTN-ON studies influenced your clinical practice?
| 1 session | |
| Justin Davies | Watch now |
Part 8
Thinking about the SPYRAL HTN-OFF and SPYRAL HTN-ON studies, what are the take-home messages for you?
| 1 session | |
| Justin Davies | Watch now |
Part 9
Thinking about the SPYRAL HTN-OFF and SPYRAL HTN-ON studies, for you, what are the key results?
| 2 sessions | |
| Justin Davies | Watch now |
| David Kandzari | Watch now |
Part 10
Can you give an overview of the RDN SPYRAL clinical trial program?
| 2 sessions | |
| Justin Davies | Watch now |
| David Kandzari | Watch now |
Part 11
Thinking about compliance, what are the advantages of RDN over pharmacological therapy?
Part 12
How does renal denervation work?
Part 13
